We are live on ! Find out more
SRPT icon

Sarepta Therapeutics
SRPT

254 hedge funds and large institutions have $3.03B invested in Sarepta Therapeutics in 2017 Q4 according to their latest regulatory filings, with 56 funds opening new positions, 78 increasing their positions, 91 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

81% more first-time investments, than exits

New positions opened: 56 | Existing positions closed: 31

24% more capital invested

Capital invested by funds: $2.44B → $3.03B (+$593M)

13% more call options, than puts

Call options by funds: $325M | Put options by funds: $287M

9% more funds holding

Funds holding: 233 → 254 (+21)

1.94% more ownership

Funds ownership: 83.52% → 85.46% (+1.9%)

14% less repeat investments, than reductions

Existing positions increased: 78 | Existing positions reduced: 91

17% less funds holding in top 10

Funds holding in top 10: 6 → 5 (-1)

Holders
254
Holders Change
+21
Holders Change %
+9.01%
% of All Funds
5.76%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.11%
New
56
Increased
78
Reduced
91
Closed
31
Calls
$325M
Puts
$287M
Net Calls
+$38M
Net Calls Change
-$18.1M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$184M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$57.6M
3
Morgan Stanley
Morgan Stanley
New York
+$30M
4
PP
PDT Partners
New York
+$30M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$25.3M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$84M
2
CCM
Camber Capital Management
Massachusetts
-$58.3M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$56.4M
4
TCP
Tourbillon Capital Partners
New York
-$32M
5
State Street
State Street
Massachusetts
-$29.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wolverine Trading
101
Wolverine Trading
Illinois
$2.46M -$1.64M -30,902 -41%
GPCM
102
Granite Point Capital Management
Massachusetts
$2.46M -$122K -2,300 -5%
ProShare Advisors
103
ProShare Advisors
Maryland
$2.44M +$190K +3,592 +9%
ACM
104
Asymmetry Capital Management
California
$2.4M -$3.28M -61,941 -59%
First Trust Advisors
105
First Trust Advisors
Illinois
$2.38M -$784K -14,798 -26%
Fisher Asset Management
106
Fisher Asset Management
Washington
$2.37M +$318 +6 +0%
BF
107
BOK Financial
Oklahoma
$2.37M +$406K +7,659 +22%
CS
108
Candriam SCA
Luxembourg
$2.34M +$2.22M +42,000 New
AIG
109
American International Group
New York
$2.29M +$80.6K +1,522 +4%
PAMU
110
Pictet Asset Management (UK)
United Kingdom
$2.24M +$201K +3,800 +10%
JG
111
Jefferies Group
New York
$2.23M +$2.12M +40,000 New
TD Asset Management
112
TD Asset Management
Ontario, Canada
$2.06M +$938K +17,700 +91%
DG
113
Delek Group
Israel
$2.06M +$1.96M +36,998 New
PCM
114
Prelude Capital Management
New York
$2.01M -$2.55M -48,165 -57%
State Board of Administration of Florida Retirement System
115
State Board of Administration of Florida Retirement System
Florida
$1.87M +$211K +3,990 +14%
SEI Investments
116
SEI Investments
Pennsylvania
$1.83M +$560K +10,579 +47%
Stifel Financial
117
Stifel Financial
Missouri
$1.83M +$339K +6,400 +24%
OC
118
Oppenheimer & Co
New York
$1.83M -$40.4K -762 -2%
SGH
119
Sivik Global Healthcare
Connecticut
$1.67M +$1.59M +30,000 New
ARTA
120
A.R.T. Advisors
New York
$1.66M +$1.58M +29,900 New
TAM
121
Tocqueville Asset Management
New York
$1.65M +$1.57M +29,575 New
BBHC
122
Brown Brothers Harriman & Co
New York
$1.58M -$159K -3,000 -10%
MIM
123
MetLife Investment Management
New Jersey
$1.54M +$1.46M +27,646 New
Jane Street
124
Jane Street
New York
$1.54M -$2.1M -39,587 -59%
SIA
125
Sit Investment Associates
Minnesota
$1.52M -$310K -5,850 -18%
3 4
5
6 7

SRPT Hedge Fund Activity: Q4 2017 in Review

254 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Sarepta Therapeutics (SRPT) for Q4 2017, worth a combined $3.03B — up 24% from $2.44B a quarter earlier.

Buyers outnumbered sellers: 56 funds opened new SRPT positions and 31 closed out — a net gain of 25 holders — while 78 added to existing stakes and 91 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $184M. The largest seller was Citadel Advisors, cutting an estimated $84M.

  • 254 institutional investors held Sarepta Therapeutics (SRPT) as of Q4 2017, up from 233 in Q3 2017.
  • Funds reported $3.03B of Sarepta Therapeutics stock for Q4 2017, up 24% quarter-over-quarter.
  • 56 funds opened new Sarepta Therapeutics positions in Q4 2017 and 31 closed out, a net change of +25 holders.
  • The largest Sarepta Therapeutics buyer in Q4 2017 was Fidelity Investments, an estimated $184M added.
  • The largest Sarepta Therapeutics seller in Q4 2017 was Citadel Advisors, an estimated $84M sold.

Based on aggregated 13F filings for Q4 2017.